Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 8/2007

01.08.2007 | Original Paper

Anatomic wide hepatectomy for treatment of hepatocellular carcinoma

verfasst von: Toshiya Ochiai, Teruhisa Sonoyama, Shojiro Kikuchi, Tokunari Okayama, Hiroo Konishi, Masahiro Kitagawa, Tomoyuki Tagi, Yuji Ueda, Eigo Otsuji

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to clarify the prognostic impact of the anatomic extent of hepatic resection (Hr) related to the tumor hepatic involvement (H) on patients’ survival in the treatment of hepatocellular carcinoma (HCC).

Method

The 305 patients with HCC who had undergone hepatectomy were analyzed retrospectively. The patients were classified into the anatomic wide hepatectomy (Hr > H hepatectomy, i.e. Hr was larger than H, n = 93) group and the other hepatectomies (Hr < or = H hepatectomy, i.e. Hr was equal to or smaller than H, n = 212) group. We compared the clinico-pathologic features between the two hepatectomy groups and the prognostic factors associated with postoperative HCC recurrence by using the Cox’s proportional hazard model.

Results

After median follow-up duration of 50 months (range 1–223 months), in Hr > H and Hr < or = H hepatectomy groups, the cumulative 3, 5, 10 year disease-free survival rates were 58.1, 44.6, 27.1% and 49.2, 33.0, 14.6%, respectively (P = 0.043). The overall survival was not significantly different between the groups (P = 0.401). Multivariate analysis revealed that Hr > H hepatectomy was an independent favorable factor for disease-free survival: the relative risk was 0.64 (95% confidence interval, 0.43–0.95; P = 0.026).

Conclusion

Anatomic wide (Hr > H) hepatectomy is a favorable procedure of choice in HCC for possibly reducing the risk of postoperative recurrence.
Literatur
Zurück zum Zitat Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R (2000) Results of surgical and no surgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32:1224–1229PubMedCrossRef Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R (2000) Results of surgical and no surgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32:1224–1229PubMedCrossRef
Zurück zum Zitat Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, Margarit C (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761PubMedCrossRef Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, Margarit C (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761PubMedCrossRef
Zurück zum Zitat Buell JF, Thomas MJ, Doty TC, Gersin KS, Merchen TD, Gupta M, Rudich SM, Woodle ES (2004) An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery 136:804–811PubMedCrossRef Buell JF, Thomas MJ, Doty TC, Gersin KS, Merchen TD, Gupta M, Rudich SM, Woodle ES (2004) An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery 136:804–811PubMedCrossRef
Zurück zum Zitat Couinaud C (1957) Le foie. Etudes anatomiques et chirurgicales. Masson et Cie, Paris Couinaud C (1957) Le foie. Etudes anatomiques et chirurgicales. Masson et Cie, Paris
Zurück zum Zitat Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252–259PubMedCrossRef Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M (2005) Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 242:252–259PubMedCrossRef
Zurück zum Zitat Healey JE, Schroy PC (1953) Anatomy of the biliary ducts within the human liver. Arch Surg 66:599–616 Healey JE, Schroy PC (1953) Anatomy of the biliary ducts within the human liver. Arch Surg 66:599–616
Zurück zum Zitat Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N, Kumada H (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28:930–938PubMedCrossRef Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N, Kumada H (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28:930–938PubMedCrossRef
Zurück zum Zitat Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K Inokuchi K (1984) Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 199:51–56PubMedCrossRef Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K Inokuchi K (1984) Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 199:51–56PubMedCrossRef
Zurück zum Zitat Lang BH, Poon RT, Fan ST, Wong J (2004) Influence of laparoscopy on postoperative recurrence and survival in patients with ruptured hepatocellular carcinoma undergoing hepatic resection. Br J Surg 91:444–449PubMedCrossRef Lang BH, Poon RT, Fan ST, Wong J (2004) Influence of laparoscopy on postoperative recurrence and survival in patients with ruptured hepatocellular carcinoma undergoing hepatic resection. Br J Surg 91:444–449PubMedCrossRef
Zurück zum Zitat Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer, 2nd English edn. Kanehara, Tokyo Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer, 2nd English edn. Kanehara, Tokyo
Zurück zum Zitat Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed
Zurück zum Zitat Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef
Zurück zum Zitat Miyagawa S, Kawasaki S (1998) Subsegmentectomy or segmentectomy in hepatocellular carcinoma. Hepatogastroenterology 45:2–6PubMed Miyagawa S, Kawasaki S (1998) Subsegmentectomy or segmentectomy in hepatocellular carcinoma. Hepatogastroenterology 45:2–6PubMed
Zurück zum Zitat Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, Kawano N, Morioka Y (1990) Postoperative recurrence of hepatocellular carcinoma. Ann Surg 211:28–33PubMedCrossRef Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, Kawano N, Morioka Y (1990) Postoperative recurrence of hepatocellular carcinoma. Ann Surg 211:28–33PubMedCrossRef
Zurück zum Zitat Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236:602–611PubMedCrossRef Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236:602–611PubMedCrossRef
Zurück zum Zitat Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131:311–317PubMedCrossRef Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131:311–317PubMedCrossRef
Zurück zum Zitat Shimizu T, Tajiri T, Yoshida H, Yokomuro S, Mamada Y, Taniai N, Kawano Y, Takahashi T, Arima Y, Aramaki T, Kumazaki T (2003) Hand-assisted laparoscopic hepatectomy after partial splenic embolization. Surg Endosc 17:1676PubMedCrossRef Shimizu T, Tajiri T, Yoshida H, Yokomuro S, Mamada Y, Taniai N, Kawano Y, Takahashi T, Arima Y, Aramaki T, Kumazaki T (2003) Hand-assisted laparoscopic hepatectomy after partial splenic embolization. Surg Endosc 17:1676PubMedCrossRef
Zurück zum Zitat Sobin LH, Wittekind CH (eds) (1997) TNM Classification of malignant tumours, 5th edn. Wiley-Liss, New York Sobin LH, Wittekind CH (eds) (1997) TNM Classification of malignant tumours, 5th edn. Wiley-Liss, New York
Zurück zum Zitat Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21:650–655PubMedCrossRef Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M (1995) Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 21:650–655PubMedCrossRef
Zurück zum Zitat Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S (1998) Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28:1241–1246PubMedCrossRef Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S (1998) Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28:1241–1246PubMedCrossRef
Zurück zum Zitat Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 356:802–807PubMedCrossRef Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 356:802–807PubMedCrossRef
Zurück zum Zitat Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28–35PubMedCrossRef Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28–35PubMedCrossRef
Zurück zum Zitat Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240:102–107PubMedCrossRef Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240:102–107PubMedCrossRef
Zurück zum Zitat Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Makuuchi M (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219–1222PubMedCrossRef Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Makuuchi M (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219–1222PubMedCrossRef
Zurück zum Zitat Ziparo V, Balducci G, Lucandri G, Mercantini P, Di Giacomo G, Fernandes E (2002) Indications and results of resection for hepatocellular carcinoma. Eur J Surg Oncol 28:723–728PubMedCrossRef Ziparo V, Balducci G, Lucandri G, Mercantini P, Di Giacomo G, Fernandes E (2002) Indications and results of resection for hepatocellular carcinoma. Eur J Surg Oncol 28:723–728PubMedCrossRef
Metadaten
Titel
Anatomic wide hepatectomy for treatment of hepatocellular carcinoma
verfasst von
Toshiya Ochiai
Teruhisa Sonoyama
Shojiro Kikuchi
Tokunari Okayama
Hiroo Konishi
Masahiro Kitagawa
Tomoyuki Tagi
Yuji Ueda
Eigo Otsuji
Publikationsdatum
01.08.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2007
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-007-0205-1

Weitere Artikel der Ausgabe 8/2007

Journal of Cancer Research and Clinical Oncology 8/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.